Company Guardion Health Sciences Inc Nasdaq
Equities
US40145Q2030
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Nutritional Supplements
97.2
%
| - | - | 12 | 97.2 % | - |
Ocular
2.8
%
| - | - | 0 | 2.8 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
100.0
%
| 11 | 99.8 % | 12 | 100.0 % | +11.04% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jan Hall
CEO | Chief Executive Officer | - | 23-06-18 |
Chairman | 72 | 15-06-29 | |
Katie Cox
AUD | Comptroller/Controller/Auditor | - | 23-07-24 |
Susan Klein
PRN | Corporate Officer/Principal | - | - |
Craig Sheehan
PRN | Corporate Officer/Principal | 53 | 21-06-02 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 72 | 15-06-29 | |
Mark Goldstone
BRD | Director/Board Member | 60 | 15-05-31 |
Donald Gagliano
BRD | Director/Board Member | 71 | 19-04-08 |
Michaela Griggs
BRD | Director/Board Member | - | 21-12-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,284,156 | 1,029,559 ( 80.17 %) | 0 | 80.17 % |
Company contact information
Guardion Health Sciences, Inc.
2925 Richmond Avenue Suite 1200
77098, Houston
+800 873 5141
http://www.guardionhealth.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+32.75% | 704B | |
+28.59% | 577B | |
-3.80% | 348B | |
+18.30% | 327B | |
+5.46% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.08% | 147B |